ABOUT US

Somru BioScience Inc. is a global biotechnology company and contract research organization (CRO) headquartered in Prince Edward Island, Canada. The company provides integrated drug discovery, preclinical and clinical development, bioanalytical testing, immunogenicity assessment, biomarker analysis, assay development, clinical laboratory services, biosimilar characterization, vaccine development support, and regulatory consulting services to pharmaceutical, biotechnology, vaccine, and government clients worldwide.

We also offer a wide range of quality reagents for research and diagnostics applications as well as biosimilar research and development. Our products and services portfolio are designed to help you meet your goals. We can develop custom antibodies and generate quality reagents that will enable you to accelerate the drug development process. We also have the capability to perform fit-for purpose validations for any of the above mentioned products.

In addition, we are developing a portfolio of "ready-to-use" kits for ultra-sensitive and highly specific detection of drug (innovator and biosimilar) and anti-drug (innovator and biosimilar) antibodies.